|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0030705,
umls-concept:C0031715,
umls-concept:C0033522,
umls-concept:C0034656,
umls-concept:C0070166,
umls-concept:C0178602,
umls-concept:C0205164,
umls-concept:C0255567,
umls-concept:C0441471,
umls-concept:C0456081,
umls-concept:C0547047,
umls-concept:C0683598,
umls-concept:C0918012,
umls-concept:C1521828,
umls-concept:C1708715,
umls-concept:C2346689
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2008-4-4
|
|
pubmed:abstractText |
This study evaluates the clinical impact of adjusting the loading dose of clopidogrel according to vasodilator-stimulated phosphoprotein (VASP) index in patients with clopidogrel resistance undergoing percutaneous coronary intervention (PCI).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
8
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1404-11
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18387444-Aged,
pubmed-meshheading:18387444-Angioplasty, Balloon, Coronary,
pubmed-meshheading:18387444-Cardiovascular Diseases,
pubmed-meshheading:18387444-Cell Adhesion Molecules,
pubmed-meshheading:18387444-Drug Resistance,
pubmed-meshheading:18387444-Female,
pubmed-meshheading:18387444-Humans,
pubmed-meshheading:18387444-Male,
pubmed-meshheading:18387444-Microfilament Proteins,
pubmed-meshheading:18387444-Myocardial Infarction,
pubmed-meshheading:18387444-Phosphoproteins,
pubmed-meshheading:18387444-Phosphorylation,
pubmed-meshheading:18387444-Platelet Aggregation Inhibitors,
pubmed-meshheading:18387444-Prospective Studies,
pubmed-meshheading:18387444-Ticlopidine,
pubmed-meshheading:18387444-Vasodilation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.
|
|
pubmed:affiliation |
Service de Cardiologie, Hôpital Universitaire Nord, Marseille, France. laurentbonello@yahoo.fr
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
